Detalhe da pesquisa
1.
Archival single-cell genomics reveals persistent subclones during DCIS progression.
Cell
; 186(18): 3968-3982.e15, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586362
2.
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response.
Genes Dev
; 36(9-10): 582-600, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654454
3.
EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.
Proc Natl Acad Sci U S A
; 120(28): e2220276120, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406091
4.
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
Oncologist
; 28(11): e1065-e1074, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156009
5.
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.
Mod Pathol
; 36(12): 100326, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678674
6.
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
Br J Cancer
; 124(2): 383-390, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012782
7.
CD8+ T cells inhibit metastasis and CXCL4 regulates its function.
Br J Cancer
; 125(2): 176-189, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33795809
8.
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1965-1976, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416944
9.
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Oncologist
; 25(10): e1457-e1463, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608142
10.
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.
Cancer Immunol Immunother
; 69(8): 1519-1534, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300858
11.
Musashi-2 (MSI2) supports TGF-ß signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Proc Natl Acad Sci U S A
; 113(25): 6955-60, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274057
12.
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
Dev Dyn
; 247(3): 555-564, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073171
13.
Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy.
Proc Natl Acad Sci U S A
; 111(9): 3550-5, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550512
14.
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.
Genes Dev
; 23(18): 2140-51, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19759262
15.
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
Lancet Oncol
; 17(12): 1672-1682, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789196
16.
Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1977-1978, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686493
17.
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
BMC Med
; 14(1): 168, 2016 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776519
18.
Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients.
Int J Cancer
; 134(4): 789-98, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23934967
19.
Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
N Engl J Med
; 364(10): 947-55, 2011 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388312
20.
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities.
Trends Pharmacol Sci
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744552